以证据为基础的远程保健提供的减肥干预措施对扩大覆盖范围和提高中风后服务不足群体的可及性的有效性

IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Evan Elizabeth McShan , Shahad Alrawi , Stephanie Calhoun , Taylor Gilliland , Monica Bennett , Rosemary Dubiel , Simon Driver
{"title":"以证据为基础的远程保健提供的减肥干预措施对扩大覆盖范围和提高中风后服务不足群体的可及性的有效性","authors":"Evan Elizabeth McShan ,&nbsp;Shahad Alrawi ,&nbsp;Stephanie Calhoun ,&nbsp;Taylor Gilliland ,&nbsp;Monica Bennett ,&nbsp;Rosemary Dubiel ,&nbsp;Simon Driver","doi":"10.1016/j.conctc.2025.101458","DOIUrl":null,"url":null,"abstract":"<div><div>Obesity is a risk factor for stroke, and survivors of stroke have a high rate of obesity and greater burden of obesity-related chronic conditions (e.g., heart disease, hypertension, re-occurring stroke) compared to the general population. Despite the health disparity, there is a lack of evidence-based weight-loss interventions tailored to individuals post stroke, as most health promotion programs exclude this population. Our team's work modifying and examining the efficacy of a modified version of the Diabetes Prevention Program Group Lifestyle Balance for people post stroke (GLB-CVA) is promising with results from an in-person randomized controlled trial (RCT) showing significant weight-loss (10.1 ± 16.8 lbs. [4.88 %]) and improvements in waist circumference, diastolic blood pressure, pain, social participation, eating practices, and health habits at 12-months post intervention. To expand the reach and accessibility of the GLB-CVA intervention, we will complete a RCT to assess the efficacy of telehealth delivery by enrolling 94 participants post stroke over a 3-year period. Results may provide an evidence-based, scalable telehealth weight-loss program designed for people post stroke that clinicians and community workers can use to increase accessibility to underserved groups.</div></div>","PeriodicalId":37937,"journal":{"name":"Contemporary Clinical Trials Communications","volume":"44 ","pages":"Article 101458"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of an evidence-based telehealth-delivered weight-loss intervention to expand reach and enhance access to underserved groups after stroke\",\"authors\":\"Evan Elizabeth McShan ,&nbsp;Shahad Alrawi ,&nbsp;Stephanie Calhoun ,&nbsp;Taylor Gilliland ,&nbsp;Monica Bennett ,&nbsp;Rosemary Dubiel ,&nbsp;Simon Driver\",\"doi\":\"10.1016/j.conctc.2025.101458\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Obesity is a risk factor for stroke, and survivors of stroke have a high rate of obesity and greater burden of obesity-related chronic conditions (e.g., heart disease, hypertension, re-occurring stroke) compared to the general population. Despite the health disparity, there is a lack of evidence-based weight-loss interventions tailored to individuals post stroke, as most health promotion programs exclude this population. Our team's work modifying and examining the efficacy of a modified version of the Diabetes Prevention Program Group Lifestyle Balance for people post stroke (GLB-CVA) is promising with results from an in-person randomized controlled trial (RCT) showing significant weight-loss (10.1 ± 16.8 lbs. [4.88 %]) and improvements in waist circumference, diastolic blood pressure, pain, social participation, eating practices, and health habits at 12-months post intervention. To expand the reach and accessibility of the GLB-CVA intervention, we will complete a RCT to assess the efficacy of telehealth delivery by enrolling 94 participants post stroke over a 3-year period. Results may provide an evidence-based, scalable telehealth weight-loss program designed for people post stroke that clinicians and community workers can use to increase accessibility to underserved groups.</div></div>\",\"PeriodicalId\":37937,\"journal\":{\"name\":\"Contemporary Clinical Trials Communications\",\"volume\":\"44 \",\"pages\":\"Article 101458\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary Clinical Trials Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2451865425000328\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary Clinical Trials Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451865425000328","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

肥胖是中风的一个危险因素,与一般人群相比,中风幸存者肥胖率高,肥胖相关慢性疾病(如心脏病、高血压、复发性中风)负担更重。尽管存在健康差异,但由于大多数健康促进计划将这一人群排除在外,因此缺乏针对中风后个体的基于证据的减肥干预措施。我们团队的工作是修改和检查修改版本的糖尿病预防计划对中风后人群的群体生活方式平衡(GLB-CVA)的功效,一项人体随机对照试验(RCT)的结果显示体重显著减轻(10.1±16.8磅)。[4.88%])和干预后12个月腰围、舒张压、疼痛、社会参与、饮食习惯和健康习惯的改善。为了扩大GLB-CVA干预的范围和可及性,我们将完成一项随机对照试验,通过招募94名中风后参与者,在3年的时间内评估远程医疗服务的有效性。研究结果可能为中风后患者提供一个基于证据的、可扩展的远程医疗减肥计划,临床医生和社区工作者可以利用该计划增加对服务不足群体的可及性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy of an evidence-based telehealth-delivered weight-loss intervention to expand reach and enhance access to underserved groups after stroke
Obesity is a risk factor for stroke, and survivors of stroke have a high rate of obesity and greater burden of obesity-related chronic conditions (e.g., heart disease, hypertension, re-occurring stroke) compared to the general population. Despite the health disparity, there is a lack of evidence-based weight-loss interventions tailored to individuals post stroke, as most health promotion programs exclude this population. Our team's work modifying and examining the efficacy of a modified version of the Diabetes Prevention Program Group Lifestyle Balance for people post stroke (GLB-CVA) is promising with results from an in-person randomized controlled trial (RCT) showing significant weight-loss (10.1 ± 16.8 lbs. [4.88 %]) and improvements in waist circumference, diastolic blood pressure, pain, social participation, eating practices, and health habits at 12-months post intervention. To expand the reach and accessibility of the GLB-CVA intervention, we will complete a RCT to assess the efficacy of telehealth delivery by enrolling 94 participants post stroke over a 3-year period. Results may provide an evidence-based, scalable telehealth weight-loss program designed for people post stroke that clinicians and community workers can use to increase accessibility to underserved groups.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
2.70
自引率
6.70%
发文量
146
审稿时长
20 weeks
期刊介绍: Contemporary Clinical Trials Communications is an international peer reviewed open access journal that publishes articles pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from a wide range of disciplines including medicine, life science, pharmaceutical science, biostatistics, epidemiology, computer science, management science, behavioral science, and bioethics. Contemporary Clinical Trials Communications is unique in that it is outside the confines of disease specifications, and it strives to increase the transparency of medical research and reduce publication bias by publishing scientifically valid original research findings irrespective of their perceived importance, significance or impact. Both randomized and non-randomized trials are within the scope of the Journal. Some common topics include trial design rationale and methods, operational methodologies and challenges, and positive and negative trial results. In addition to original research, the Journal also welcomes other types of communications including, but are not limited to, methodology reviews, perspectives and discussions. Through timely dissemination of advances in clinical trials, the goal of Contemporary Clinical Trials Communications is to serve as a platform to enhance the communication and collaboration within the global clinical trials community that ultimately advances this field of research for the benefit of patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信